SCHEMBL6174448

SCHEMBL6174448

CC1(Cc2ccncc2OCc2ccccc2)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.44
IKBKB O14920 2/20 0.36
NAMPT P43490 1/20 0.35
PTPRZ1 P23471 1/20 0.35
CYP19A1 P11511 3/20 0.33
CYP11B1 P15538 3/20 0.33
CYP11B2 P19099 3/20 0.33
ALDH1A1 P00352 2/20 0.33
GPBAR1 Q8TDU6 3/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
AR P10275 3/20 0.32
BUB1 O43683 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174638 0.89 IGF1R (0.43) IGF1RNAMPTALDH1A1TP53AR
SCHEMBL6175293 0.84 IGF1R (0.45) IGF1RNAMPTALDH1A1KDM4ELMNA
SCHEMBL6171403 0.83 IGF1R (0.43) IGF1RNAMPTALDH1A1LMNATP53
SCHEMBL6175170 0.82 IGF1R (0.44) IGF1RNAMPTALDH1A1LMNATP53
SCHEMBL6175255 0.82 IGF1R (0.44) IGF1RNAMPTALDH1A1LMNATP53
SCHEMBL6173238 0.82 IGF1R (0.41) IGF1RNAMPTALDH1A1KDM4ELMNA
SCHEMBL2934865 0.82 IGF1R (0.65) IGF1RAR
SCHEMBL6173181 0.81 IGF1R (0.43) IGF1RNAMPTPTPRZ1LMNATP53
SCHEMBL6171903 0.81 IGF1R (0.45) IGF1RNAMPTALDH1A1TP53AR
SCHEMBL6174148 0.81 IGF1R (0.40) IGF1RNAMPTALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed